- Home
- STCN vs VSTM Comparison
STCN vs VSTM Comparison
Compare STCN & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- VSTM
- Stock Information
- Founded
- STCN 1986
- VSTM 2010
- Country
- STCN United States
- VSTM United States
- Employees
- STCN N/A
- VSTM N/A
- Industry
- STCN Advertising
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- STCN Consumer Discretionary
- VSTM Health Care
- Exchange
- STCN Nasdaq
- VSTM Nasdaq
- Market Cap
- STCN 63.4M
- VSTM 132.0M
- IPO Year
- STCN 1994
- VSTM 2012
- Fundamental
- Price
- STCN $10.40
- VSTM $3.88
- Analyst Decision
- STCN
- VSTM Strong Buy
- Analyst Count
- STCN 0
- VSTM 8
- Target Price
- STCN N/A
- VSTM $14.57
- AVG Volume (30 Days)
- STCN 11.9K
- VSTM 1.1M
- Earning Date
- STCN 12-12-2024
- VSTM 11-06-2024
- Dividend Yield
- STCN N/A
- VSTM N/A
- EPS Growth
- STCN 203.29
- VSTM N/A
- EPS
- STCN 3.17
- VSTM N/A
- Revenue
- STCN $169,044,000.00
- VSTM $10,000,000.00
- Revenue This Year
- STCN N/A
- VSTM N/A
- Revenue Next Year
- STCN N/A
- VSTM $125.69
- P/E Ratio
- STCN $3.19
- VSTM N/A
- Revenue Growth
- STCN N/A
- VSTM N/A
- 52 Week Low
- STCN $7.36
- VSTM $2.10
- 52 Week High
- STCN $13.00
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- STCN 57.19
- VSTM 63.77
- Support Level
- STCN $9.90
- VSTM $3.11
- Resistance Level
- STCN $10.29
- VSTM $3.76
- Average True Range (ATR)
- STCN 0.39
- VSTM 0.33
- MACD
- STCN 0.11
- VSTM 0.04
- Stochastic Oscillator
- STCN 100.00
- VSTM 94.26
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.